Estera Mikina

The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer

Danuta Gąsior‐Perczak, Iwona Pałyga, Monika Szymonek et al. · PLoS ONE · 2018 · 44 citations · Full text

Medicine, Endocrinology, Oncology +14

Impact of BRAF V600E and TERT Promoter Mutations on Response to Therapy in Papillary Thyroid Cancer

Tomasz Trybek, Agnieszka Walczyk, Danuta Gąsior‐Perczak et al. · Endocrinology · 2019 · 42 citations · Full text

Medicine, Molecular Genetics, Oncology +16

The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence

Aldona Kowalska, Agnieszka Walczyk, Iwona Pałyga et al. · PLoS ONE · 2016 · 29 citations · Full text

Medicine, Oncology, Early Detection +14

Response to therapy of papillary thyroid cancer of known <i><scp>BRAF</scp></i> status

Aldona Kowalska, Agnieszka Walczyk, Artur Kowalik et al. · Clinical Endocrinology · 2017 · 22 citations

Medicine, Molecular Genetics, Oncology +16

Coexisting Germline CHEK2 and Somatic BRAFV600E Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course

Danuta Gąsior‐Perczak, Artur Kowalik, Agnieszka Walczyk et al. · Cancers · 2019 · 17 citations · Full text

Medicine, Oncology, Pathology +17